CompletedNCT06751875
Preventing depression relapse after electroconvulsive therapy
About this title
Read the official source — NCT06751875Medication studyAges 18+Belgium
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- WilrijkSee all locations and recruitment
Study information
Study start dateStarted: July 26, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 96
- Sponsor
- Universiteit Antwerpen
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Belgium
- Age range
- Over 18 Years
- Official registry ID
- NCT06751875
- Official title
Show the full official title
Preventing Relapse After Successful Electroconvulsive Therapy for Depression. A Randomized Controlled Trial on Lithium as add-on to Personalized Maintenance ECT.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Wilrijk
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Universiteit Antwerpen.
Did this study involve medication?
Yes. The study involved medication, including lithium.
Who was this study for?
Listed age limits: from 18 years.
Want to explore more studies?
Explore studiesRelated studies
Intranasal Esketamine Added to Standard Care for Adults at Imminent Suicide Risk
A Double-Blind, Double-Randomization, Placebo-Controlled Study of the Efficacy of Intravenous Esketamine in Adult Subjects with Treatment-Resistant Depression